CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK

Summary

GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

In 2012, the UK`s population was approximately 63.7 million. The major factors contributing to the growth in the population are increase in net migration and decrease in death rate. The UK policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in the UK was estimated at $24.1 billion in 2012 and is expected to reach approximately $31.7 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 3.5%. The medical devices market size was approximately $12 billion in 2012 and is expected to reach approximately $17.5 billion by 2020 with a projected CAGR of 4.8%.

The positive trends in the UK healthcare market can be attributed primarily to -
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes -
- Overview of the pharmaceutical and medical devices market of the UK including the market size, market segmentation, key drivers and barriers.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Novartis, Sanofi and AstraZeneca. The key players covered for the medical devices market are Medtronic, Siemens Healthcare, Essilor Internaltional, Hoffmann-La Roche, and Coloplast.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices.
- A detailed analysis of the political and economic environment of the UK including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of the UK

Reasons to buy

The report on the UK comprehensively covers both the pharmaceutical and the medical devices markets of the UK. The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market of the UK.
- Drive revenue by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the the UK healthcare market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of the UK

Table Of Contents

Table of Contents

1 Table of Contents 7
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 20
2.1 GlobalData Report Guidance 20
3 Overview of Pharmaceutical and Medical Device Markets 21
3.1 Pharmaceutical Market 21
3.1.1 Market Overview 21
3.1.2 Pharmaceutical Exports and Imports 25
3.1.3 Supply Channels 26
3.1.4 Market Segments 29
3.1.5 Overview of Top Five Disease Areas 35
3.1.6 Major Players 41
3.2 Medical Device Market 89
3.2.1 Market Overview 89
3.2.2 Overview of Top Five Segments 91
3.2.3 Diagnostics Market 102
3.2.4 Major Players 104
3.3 Market Drivers and Barriers 137
3.3.1 Drivers 137
3.3.2 Barriers 138
4 Market Access 140
4.1 Reimbursement and Payer Landscape 140
4.1.1 Overview of Healthcare System 140
4.1.2 Reimbursement Process 145
4.1.3 Overview of Insurance Providers 149
4.1.4 Patient Share in Healthcare Spending 151
4.1.5 Prescription Drug Price Trends 152
4.1.6 Pricing Policies 153
4.2 Regulatory Landscape 157
4.2.1 Overview of Regulatory Agencies 157
4.2.2 Market Authorization Procedure for Pharmaceutical Products 159
4.2.3 New Medical Device Approval Process 169
4.2.4 Licensing Process for Pharmaceutical Manufacturing 176
4.2.5 Intellectual Property Rights 176
4.2.6 Clinical Trial Regulations 178
4.2.7 Pharmaceutical Advertising Regulations 181
4.2.8 Pharmacy Regulations 182
4.2.9 Labeling and Packaging Regulations 183
5 Country Analysis 185
5.1 Political Environment 185
5.1.1 Political Structure 185
5.1.2 Analysis of the Current Political Environment 186
5.1.3 Healthcare Policy Initiatives 187
5.2 Economic Landscape 188
5.3 Economic Indicators 191
5.3.1 Gross Domestic Product 191
5.3.2 Gross National Income 196
5.3.3 Inflation 197
5.3.4 Currency Exchange Rate 199
5.3.5 Foreign Direct Investment 200
5.3.6 Foreign Exchange Reserves 201
5.3.7 Trade Balance 202
5.3.8 General Government Structural Balance 204
5.3.9 General Government Net Debt 205
5.3.10 External Debt 207
5.3.11 Major Industries 208
5.4 Demographics 209
5.4.1 Population 209
5.4.2 Education and Literacy 233
5.4.3 Employment 236
5.4.4 Disease Burden 237
5.5 Healthcare Infrastructure 242
5.5.2 Healthcare Parameters 244
5.5.3 Environmental Health 246
5.5.4 Healthcare Personnel 251
5.6 Healthcare Expenditure 254
5.6.1 Overview 254
5.6.2 Major Components of Healthcare Spending 255
5.6.3 Public and Private Sector Share 257
5.6.4 Spending in Pharmaceutical RandD 258
5.7 Trade Associations 260
5.8 Trade Fairs 262
6 Opportunities and Challenges 263
6.1 Opportunities 263
6.2 Challenges 264
7 Appendix 266
7.1 Abbreviations 266
7.2 Bibliography 269
7.3 Methodology 282
7.3.1 Coverage 282
7.3.2 Secondary Research 283
7.3.3 Forecasting 284
7.3.4 Expert Panel Validation 284
7.4 Disclaimer 284



List of Tables

Table 1: Pharmaceutical Market, UK, Revenue ($bn), 2007-2012 23
Table 2: Pharmaceutical Market, UK, Revenue Forecast ($bn), 2013-2020 24
Table 3: Pharmaceutical Market, UK, Top Products by Net Ingredient Cost ($m), 2012 24
Table 4: Pharmaceutical Market, UK, Exports and Imports ($bn), 2007-2012 25
Table 5: Pharmaceutical Market, UK, Community Pharmacies, 2007-2012 28
Table 6: Pharmaceutical Market, UK, Prescription Items Dispensed Generically in England, 2007-2011 30
Table 7: Pharmaceutical Market, Global, Drugs Going Off-patent, Revenue ($m), 2011-2015 31
Table 8: Pharmaceutical Market, UK, OTC, Revenue ($bn), 2008-2011 33
Table 9: Pharmaceutical Market, UK, Major Segments, OTC Pharmaceuticals, Revenue ($m), 2011 34
Table 10: Pharmaceutical Market, UK, Top Five Disease Areas, Net Ingredient Cost ($bn), 2012 35
Table 11: Pharmaceutical Market, UK, NHS Gross Expenditure on Neurological Problems ($bn), 2006-2011 36
Table 12: Pharmaceutical Market, UK, NHS Gross Expenditure on Cardiovascular Diseases ($bn), 2006-2011 37
Table 13: Pharmaceutical Market, UK, NHS Gross Expenditure on Respiratory System Problems ($bn), 2006-2011 38
Table 14: Pharmaceutical Market, UK, NHS Gross Expenditure on Endocrine, Nutritional and Metabolic Problems ($bn), 2006-2011 39
Table 15: Pharmaceutical Market, UK, NHS Gross Expenditure on Blood Disorders, ($bn), 2006-2011 40
Table 16: Pfizer, Global, Major Products, Revenue ($bn), 2012 42
Table 17: Pfizer, Global, Late-stage Pipeline, 2013 43
Table 18: GlaxoSmithKline, Global, Major Products, Revenue ($bn), 2012 53
Table 19: GlaxoSmithKline, Global, Late-Stage Pipeline, 2013 54
Table 20: Novartis, Global, Major Products, Revenue ($m), 2012 62
Table 21: Novartis, Global, Planned Filings, 2012 to ? 2016 63
Table 22: Sanofi, Global, Major Products, Revenue ($bn), 2012 70
Table 23: Sanofi, Global, Late-stage Pipeline, 2013 71
Table 24: AstraZeneca, Global, Major Products, Revenue ($bn), 2012 78
Table 25: AstraZeneca, Global, Late-Stage Pipeline, 2013 79
Table 26: Medical Device Market ($bn), UK, Revenue ($bn), 2007-2012 89
Table 27: Medical Device Market, UK, Revenue Forecast ($bn), 2013-2020 90
Table 28: Medical Device Market, UK, Revenue by Segment ($bn), 2012 91
Table 29: Medical Device Market, UK, Ophthalmic Device Market, Revenue ($bn), 2007-2012 92
Table 30: Medical Device Market, UK, Sales Trends for Major Players*, Ophthalmic Devices, 2011 93
Table 31: Medical Device Market, UK, Orthopedic Device Market, Revenue ($m), 2007-2012 94
Table 32: Medical Device Market, UK, Sales Trends for Major Players*, Orthopedic Devices, 2011 95
Table 33: Medical Device Market, UK, Wound Care Management Device Market, Revenue ($m), 2007-2012 96
Table 34: Medical Device Market, UK, Sales Trends for Major Players*, In Vitro Diagnostics, 2011 97
Table 35: Medical Device Market, UK, Cardiovascular Device Market, Revenue ($m), 2007-2012 98
Table 36: Medical Device Market, UK, Sales Trends for Major Players*, Cardiovascular Devices, 2011 99
Table 37: Medical Device Market, UK, Drug Delivery Device Market, Revenue ($m), 2007-2012 100
Table 38: Medical Device Market, UK, Sales Trends for Major Players*, Drug Delivery Devices, 2011 101
Table 39: Medical Device Market, UK, Diagnostics Market, Revenue ($m), 2007-2012 102
Table 40: Medical Device Market, UK, Diagnostics Market, Revenue Forecast ($m), 2013-2020 103
Table 41: Medical Device Market, UK, Major Players, Revenue ($m), 2011 104
Table 42: Medtronic, Global, Major Products, ]Revenue ($bn), 2012 106
Table 43: Siemens, Global, Major Products, Revenue ($m), 2012 112
Table 44: Essilor International, Global, Major Segments, Revenue ($m), 2011 117
Table 45: Roche, Global, Major Products, Revenues ($m), 2012 124
Table 46: Coloplast, Global, Major Segments, Revenue ($m), 2012 130
Table 47: Healthcare System, UK, NHS Authorities and Trusts in England, 2013 143
Table 48: Healthcare Spending, UK, Out-of-Pocket Expenditure (%), 2007-2012 151
Table 49: Price of Prescription Drugs, UK, Change in Average Price of Prescription Drugs (%), 2007-2011 152
Table 50: Price Adjustments Under PPRS, UK, Price Adjustments (%), 2009-2013 154
Table 51: Bilateral Comparisons of Ex-Manufacturer Prices, 2004-2010 156
Table 52: Economic Indicators, UK, Gross Domestic Product Per Capita ($’000), 2007-2012 192
Table 53: Economic Indicators, UK, Gross Domestic Product Per Capita ($’000), Forecast, 2013-2020 193
Table 54: Economic Indicators, UK, Gross Domestic Product Annual Growth (%), 2007-2012 194
Table 55: Economic Indicators, UK, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 195
Table 56: Economic Indicators, UK, Gross National Income Per Capita ($’000), 2007-2012 196
Table 57: Economic Indicators, UK, Average Consumer Price Index, 2007-2012 197
Table 58: Economic Indicators, UK, Average Consumer Price Annual Change (%), 2007-2012 198
Table 59: Economic Indicators, UK, Currency Exchange Rate (£/$), 2007-2012 199
Table 60: Economic Indicators, UK, Foreign Direct Investment ($bn), 2007-2012 200
Table 61: Economic Indicators, UK, Foreign Exchange Reserves ($bn), 2007-2012 201
Table 62: Economic Indicators, UK, Exports of Goods and Services ($bn), 2007-2012 202
Table 63: Economic Indicators, UK, Imports of Goods and Services ($bn), 2007-2012 203
Table 64: Economic Indicators, UK, Government Structural Balance ($bn), 2007-2012 204
Table 65: Economic Indicators, UK, General Government Net Debt (% of GDP), 2007-2012 205
Table 66: Economic Indicators, UK, General Government Net Debt (% of GDP), Forecast, 2013-2020 206
Table 67: Economic Indicators, UK, External Debt ($bn), 2007-2012 207
Table 68: Economic Indicators, UK, Major Industries, Turnover ($bn), 2010-2011 208
Table 69: Demographics, UK, Population (million), 2007-2012 210
Table 70: Demographics, UK, Population (million), Forecast, 2013-2020 211
Table 71: Demographics, UK, Population, Urban and Rural Population Share (%), 2007-2012 212
Table 72: Demographics, UK, Population, Urban and Rural Population Share (%), Forecast, 2013-2020 213
Table 73: Demographics, UK, Population Distribution by Age Group (%), 2007-2012 215
Table 74: Demographics, UK, Population Distribution by Age Group (%), Forecast, 2013-2020 215
Table 75: Demographics, UK, Population Distribution by Age Group (%), 2011 216
Table 76: Demographics, UK, Births (Per 1,000 Population), 2007-2012 217
Table 77: Demographics, UK, Mortality (Per 1,000 Population), 2007-2012 218
Table 78: Demographics, UK, Major Causes of Mortality (‘000), 2011 219
Table 79: Demographics, UK, Major Causes of Mortality (‘000) in England and Wales, 2011 221
Table 80: Demographics, UK, Major Causes of Mortality (‘000) in Scotland, 2011 223
Table 81: Demographics, UK, Major Causes of Mortality (‘000) in Northern Ireland, 2011 225
Table 82: Demographics, UK, Children Table 83: Demographics, UK, Immunization Rate (%), 2007-2012 227
Table 84: Demographics, UK, Major Causes of Male Mortality (‘000), 2011 228
Table 85: Demographics, UK, Major Causes of Female Mortality (‘000), 2011 229
Table 86: Demographics, UK, Gender Ratio (M/F), 2007-2012 230
Table 87: Demographics, UK, Life Expectancy at Birth (Years), 2007-2012 232
Table 88: Demographics, UK, Life Expectancy at Birth (Years), Forecast, 2013-2020 232
Table 89: Demographics, UK, Student Enrollment by Level of Education (%), 2007-2012 234
Table 90: Demographics, UK, Higher Education by Subject Area, Student Enrollment (‘000), 2011-2012 235
Table 91: Demographics, UK, Unemployment Rate (%), 2007-2012 236
Table 92: Demographics, UK, Major Diseases, Prevalence (million), 2010 238
Table 93: Demographics, UK, Major Diseases in England, Prevalence (%), 2011-2012 239
Table 94: Demographics, UK, Major Diseases, DALYs (Per 100,000 Population), 2004 241
Table 95: Healthcare Infrastructure, UK, Beds (Per 1,000 Population) by Type of Service, 2007-2012 242
Table 96: Healthcare Infrastructure, UK, Diagnostic Equipment (Per 1,000,000 Population), 2007-2012 243
Table 97: Healthcare Infrastructure, UK, Hospital Beds (Per 1,000 Population), 2007-2012 244
Table 98: Healthcare Infrastructure, UK, Practicing Physicians (Per 1,000 Population), 2007-2012 245
Table 99: Environmental Health, UK, CO2 Emissions (Million Tons), 2007-2012 248
Table 100: Environmental Health, UK, CH4 Emissions (Million Tons), 2007-2012 249
Table 101: Environmental Health, UK, PM10 (micrograms per cubic meter), 2007-2012 250
Table 102: Healthcare Personnel, UK, General Practitioners (Per 1,000 Population), 2007-2012 251
Table 103: Healthcare Personnel, UK, Nurses (Per 1,000 Population), 2007-2012 252
Table 104: Healthcare Personnel, UK, Dentists (Per 1,000 Population), 2007-2012 253
Table 105: Healthcare Expenditure, UK, Healthcare Expenditure ($bn), 2007-2012 254
Table 106: Healthcare Expenditure, UK, Primary Healthcare Expenditure, Share of Major Components (%), 2011-2012 255
Table 107: Healthcare Expenditure, UK, Secondary Healthcare Expenditure, Share of Major Components (%), 2011-2012 256
Table 108: Healthcare Expenditure, UK, Healthcare Expenditure, Public-Private Share (%), 2007-2012 257
Table 109: Healthcare Expenditure, UK, Pharmaceutical RandD Expenditure ($bn), 2007-2012 259
Table 110: Healthcare Expenditure, UK, Pharmaceutical RandD Expenditure (%), 2010 259
Table 111: Major Healthcare Trade Fairs, UK, 2013-2014 262



List of Figures

Figure 1: Pharmaceutical Market, UK, Revenue ($bn), 2007-2012 23
Figure 2: Pharmaceutical Market, UK, Revenue Forecast ($bn), 2013-2020 24
Figure 3: Pharmaceutical Market, UK, Exports and Imports ($bn), 2007-2012 25
Figure 4: Pharmaceutical Market, UK, Distribution Channel, 2013 27
Figure 5: Pharmaceutical Market, UK, Community Pharmacies, 2007-2012 28
Figure 6: Pharmaceutical Market, UK, Prescription Items Dispensed Generically in England, 2007-2011 30
Figure 7: Pharmaceutical Market, UK, OTC, Revenue ($bn), 2008-2011 33
Figure 8: Pharmaceutical Market, UK, Major Segments, OTC Pharmaceuticals, Revenue ($m), 2011 34
Figure 9: Pharmaceutical Market, UK, Top Five Disease Areas, Net Ingredient Cost ($bn), 2012 35
Figure 10: Pharmaceutical Market, UK, NHS Gross Expenditure on Neurological Problems ($bn), 2006-2011 36
Figure 11: Pharmaceutical Market, UK, NHS Gross Expenditure on Cardiovascular Diseases ($bn), 2006-2011 37
Figure 12: Pharmaceutical Market, UK, NHS Gross Expenditure on Respiratory System Problems ($bn), 2006-2011 38
Figure 13: Pharmaceutical Market, UK, NHS Gross Expenditure on Endocrine, Nutritional and Metabolic Problems ($bn), 2006-2011 39
Figure 14: Pharmaceutical Market, UK, NHS Gross Expenditure on Blood Disorders, ($bn), 2006-2011 40
Figure 15: Medical Device Market, UK, Revenue ($bn), 2007-2012 89
Figure 16: Medical Device Market, UK, Revenue Forecast ($bn), 2013-2020 90
Figure 17: Medical Device Market, UK, Revenue by Segment ($bn), 2012 91
Figure 18: Medical Device Market, UK, Ophthalmic Device Market, Revenue ($bn), 2007-2012 92
Figure 19: Medical Device Market, UK, Sales Trends for Major Players*, Ophthalmic Devices, 2007-2011 93
Figure 20: Medical Device Market, UK, Orthopedic Device Market, Revenue ($m), 2007-2012 94
Figure 21: Medical Device Market, UK, Sales Trends for Major Players*, Orthopedic Devices, 2007-2011 95
Figure 22: Medical Device Market, UK, Wound Care Management Device Market, Revenue ($m), 2007-2012 96
Figure 23: Medical Device Market, UK, Sales Trends for Major Players*, Wound Care Management Devices, 2007-2011 97
Figure 24: Medical Device Market, UK, Cardiovascular Device Market, Revenue ($m), 2007-2012 98
Figure 25: Medical Device Market, UK, Sales Trends for Major Players*, Cardiovascular Devices, 2007-2011 99
Figure 26: Medical Device Market, UK, Drug Delivery Device Market, Revenue ($m), 2007-2012 100
Figure 27: Medical Device Market, UK, Sales Trends for Major Players*, Drug Delivery Devices, 2007-2011 101
Figure 28: Medical Device Market, UK, Diagnostics Market, Revenue ($m), 2007-2012 102
Figure 29: Medical Device Market, UK, Diagnostics Market, Revenue Forecast ($m), 2013-2020 103
Figure 30: Medical Device Market, UK, Major Players, Revenue ($m), 2011 104
Figure 31: Healthcare Market, UK, Drivers and Barriers, 2013 139
Figure 32: Healthcare System, UK, Primary Care Providers, 2013 140
Figure 33: Healthcare System, UK, Secondary Care Providers, 2013 140
Figure 34: Healthcare System, UK, 2013 144
Figure 35: Healthcare System, UK, Pricing and Reimbursement Process, 2013 146
Figure 36: Healthcare System, UK, Pricing of a New Pharmaceutical Product, 2013 147
Figure 37: Healthcare System, UK, Impact of Reforms on Pharmaceutical Pricing System, 2013 148
Figure 38: Healthcare Spending, UK, Out-of-Pocket Expenditure (%), 2007-2012 151
Figure 39: Price of Prescription Drugs, UK, Change in Average Price of Prescription Drugs (%), 2007-2011 152
Figure 40: Healthcare System, UK, MHRA Structure, 2013 158
Figure 41: Healthcare System, UK, National Procedure for Market Authorization, 2013 159
Figure 42: Healthcare System, EU, Centralized Procedure, Pre-Submission, 2011 161
Figure 43: Healthcare System, EU, Centralized Procedure, Marketing Authorization, Pre-Opinion Phase, 2011 163
Figure 44: Healthcare System, EU, Centralized Procedure, Marketing Authorization, Post-opinion Phase, 2011 165
Figure 45: Healthcare System, EU, Decentralized Procedure, 2011 167
Figure 46: Healthcare System, EU, Mutual Recognition Procedure, 2013 168
Figure 47: Healthcare System, EU, Conformity Assessment of Class I Medical Devices, 2013 172
Figure 48: Healthcare System, EU, Conformity Assessment of Class IIa Medical Devices, 2013 173
Figure 49: Healthcare System, EU, Conformity Assessment of Class IIb Medical Devices, 2013 174
Figure 50: Healthcare System, EU, Conformity Assessment of Class III Medical Devices, 2013 175
Figure 51: Healthcare System, UK, Patent Approval Process, 2013 177
Figure 52: Healthcare System, UK, Clinical Trial Regulation Process for Medicines, 2013 179
Figure 53: Healthcare System, UK, Clinical Trial Regulation Process for Medical Devices, 2013 180
Figure 54: Economic Indicators, UK, Gross Domestic Product Per Capita ($’000), 2007-2012 192
Figure 55: Economic Indicators, UK, Gross Domestic Product Per Capita ($’000), Forecast, 2013-2020 193
Figure 56: Economic Indicators, UK, Gross Domestic Product Annual Growth (%), 2007-2012 194
Figure 57: Economic Indicators, UK, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 195
Figure 58: Economic Indicators, UK, Gross National Income Per Capita ($’000), 2007-2012 196
Figure 59: Economic Indicators, UK, Average Consumer Price Index, 2007-2012 197
Figure 60: Economic Indicators, UK, Average Consumer Price Annual Change (%), 2007-2012 198
Figure 61: Economic Indicators, UK, Currency Exchange Rate (£/$), 2007-2012 199
Figure 62: Economic Indicators, UK, Foreign Direct Investment ($bn), 2007-2012 200
Figure 63: Economic Indicators, UK, Foreign Exchange Reserves ($bn), 2007-2012 201
Figure 64: Economic Indicators, UK, Exports of Goods and Services ($bn), 2007-2012 202
Figure 65: Economic Indicators, UK, Imports of Goods and Services ($bn), 2007-2012 203
Figure 66: Economic Indicators, UK, Government Structural Balance ($bn), 2007-2012 204
Figure 67: Economic Indicators, UK, General Government Net Debt (% of GDP), 2007-2012 205
Figure 68: Economic Indicators, UK, General Government Net Debt (% of GDP), Forecast, 2013-2020 206
Figure 69: Economic Indicators, UK, External Debt ($bn), 2007-2012 207
Figure 70: Economic Indicators, UK, Major Industries, Turnover ($bn), 2010, 2011 208
Figure 71: Demographics, UK, Population (million), 2007-2012 210
Figure 72: Demographics, UK, Population (million), Forecast, 2013-2020 211
Figure 73: Demographics, UK, Population, Urban and Rural Population Share (%), 2007-2012 212
Figure 74: Demographics, UK, Population, Urban and Rural Population Share (%), Forecast, 2013-2020 213
Figure 75: Demographics, UK, Population Distribution by Age Group (%), 2007-2012 214
Figure 76: Demographics, UK, Population Distribution by Age Group (%), Forecast, 2013-2020 215
Figure 77: Demographics, UK, Population Distribution by Age Group (%), 2011 216
Figure 78: Demographics, UK, Births (Per 1,000 Population), 2007-2012 217
Figure 79: Demographics, UK, Mortality (Per 1,000 Population), 2007-2012 218
Figure 80: Demographics, UK, Major Causes of Mortality (‘000), 2011 219
Figure 81: Demographics, UK, Major Causes of Mortality (‘000) in England and Wales, 2011 220
Figure 82: Demographics, UK, Major Causes of Mortality (‘000) in Scotland, 2011 222
Figure 83: Demographics, UK, Major Causes of Mortality (‘000) in Northern Ireland, 2011 224
Figure 84: Demographics, UK, Children Figure 85: Demographics, UK, Immunization Rate (%), 2007-2012 227
Figure 86: Demographics, UK, Major Causes of Male Mortality (‘000), 2011 228
Figure 87: Demographics, UK, Major Causes of Female Mortality (‘000), 2011 229
Figure 88: Demographics, UK, Gender Ratio (M/F), 2007-2012 230
Figure 89: Demographics, UK, Life Expectancy at Birth (Years), 2007-2012 231
Figure 90: Demographics, UK, Life Expectancy at Birth (Years), Forecast, 2013-2020 232
Figure 91: Demographics, UK, Student Enrollment by Level of Education (%), 2007-2012 234
Figure 92: Demographics, UK, Higher Education by Subject Area, Student Enrollment (‘000), 2011-2012 235
Figure 93: Demographics, UK, Unemployment Rate (%), 2007-2012 236
Figure 94: Demographics, UK, Major Diseases, Prevalence (million), 2010 238
Figure 95: Demographics, UK, Major Diseases in England, Prevalence (%), 2011-2012 239
Figure 96: Demographics, UK, Major Diseases, DALYs (Per 100,000 Population), 2009 240
Figure 97: Healthcare Infrastructure, UK, Beds (Per 1,000 Population) by Type of Service, 2007-2012 242
Figure 98: Healthcare Infrastructure, UK, Diagnostic Equipment (Per 1,000,000 Population), 2007-2012 243
Figure 99: Healthcare Infrastructure, UK, Hospital Beds (Per 1,000 Population), 2007-2012 244
Figure 100: Healthcare Infrastructure, UK, Practicing Physicians (Per 1,000 Population), 2007-2012 245
Figure 101: Environmental Health, UK, CO2 Emissions (Million Tons), 2007-2012 248
Figure 102: Environmental Health, UK, CH4 Emissions (Million Tons), 2007-2012 249
Figure 103: Environmental Health, UK, PM10 (micrograms per cubic meter), 2007-2012 250
Figure 104: Healthcare Personnel, UK, General Practitioners (Per 1,000 Population), 2007-2012 251
Figure 105: Healthcare Personnel, UK, Nurses (Per 1,000 Population), 2007-2012 252
Figure 106: Healthcare Personnel, UK, Dentists (Per 1,000 Population), 2007-2012 253
Figure 107: Healthcare Expenditure, UK, Healthcare Expenditure ($bn), 2007-2012 254
Figure 108: Healthcare Expenditure, UK, Primary Healthcare Expenditure, Share of Major Components (%), 2011-2012 255
Figure 109: Healthcare Expenditure, UK, Secondary Healthcare Expenditure, Share of Major Components (%), 2011-2012 256
Figure 110: Healthcare Expenditure, UK, Healthcare Expenditure, Public-Private Share (%), 2007-2012 257
Figure 111: Healthcare Expenditure, UK, Pharmaceutical RandD Expenditure ($bn), 2007-2012 258
Figure 112: Healthcare Expenditure, UK, Pharmaceutical RandD Expenditure (%), 2010 259
Figure 113: Healthcare Market, UK, Opportunities and Challenges, 2013 265

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Healthcare Workforce Management Systems Market by Solution (Talent Management, Time & Attendance, Scheduling, Optimization Services), by Mode of Delivery (Cloud-based, Web-based), by End-User (Hospital, Long Term Care) - Global Forecast to 2019

Healthcare Workforce Management Systems Market by Solution (Talent Management, Time & Attendance, Scheduling, Optimization Services), by Mode of Delivery (Cloud-based, Web-based), by End-User (Hospital, Long Term Care) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

The global healthcare workforce management systems market is expected to grow at a double digit CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $1,453.8 million by 2019. The ...

ICT investment trends in healthcare - Enterprise ICT spending patterns through to the end of 2015

ICT investment trends in healthcare - Enterprise ICT spending patterns through to the end of 2015

  • $ 2 995
  • Industry report
  • September 2014
  • by Kable

Summary This report presents the findings from a survey of 173 healthcare providers regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how healthcare ...

Public Health Partnering Terms and Agreements

Public Health Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Public Health Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter public health partnering deals. The majority of deals are discovery, ...

Global Healthcare Providers

June 2014 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.